Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026413
Filing Date
2021-05-14
Accepted
2021-05-14 16:09:13
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_chinapharmahold.htm 10-Q 277888
2 CERTIFICATION f10q0321ex31-1_chinapharma.htm EX-31.1 8831
3 CERTIFICATION f10q0321ex31-2_chinapharma.htm EX-31.2 9335
4 CERTIFICATION f10q0321ex32-1_chinapharma.htm EX-32.1 7590
  Complete submission text file 0001213900-21-026413.txt   2333627

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20210331.xml EX-101.INS 248108
6 XBRL SCHEMA FILE cphi-20210331.xsd EX-101.SCH 39085
7 XBRL CALCULATION FILE cphi-20210331_cal.xml EX-101.CAL 37301
8 XBRL DEFINITION FILE cphi-20210331_def.xml EX-101.DEF 160739
9 XBRL LABEL FILE cphi-20210331_lab.xml EX-101.LAB 312473
10 XBRL PRESENTATION FILE cphi-20210331_pre.xml EX-101.PRE 169021
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 21924628
SIC: 2834 Pharmaceutical Preparations